Web Results

en.wikipedia.org/wiki/Nilotinib

Nilotinib (AMN107, trade name Tasigna), in the form of the hydrochloride monohydrate salt, is a small-molecule tyrosine kinase inhibitor approved for the ...

medlineplus.gov/druginfo/meds/a608002.html

Sep 15, 2016 ... Nilotinib: learn about side effects, dosage, special precautions, and more on MedlinePlus.

www.michaeljfox.org/foundation/news-detail.php?nilotinib-update-where-we-stand-with-cancer-drug-for-parkinson

Jul 12, 2016 ... Among the partners' goals: planning a double-blind, placebo-controlled clinical trial of nilotinib, which MJFF hopes can begin in 2017.

www.cancerresearchuk.org/about-cancer/cancer-in-general/treatment/cancer-drugs/drugs/nilotinib

Find out what nilotinib is, how you have it and other important information about taking nilotinib.

www.us.tasigna.com

Learn how TASIGNA® (nilotinib) can be prescribed to treat Ph+ positive chronic myeloid leukemia. See full Safety & Prescribing Info and BOXED WARNING.

www.cancer.gov/about-cancer/treatment/drugs/fda-nilotinib

Jul 3, 2013 ... Information from the FDA about the approval of nilotinib and the clinical trials that led to the approval.

chemocare.com/chemotherapy/drug-info/Nilotinib.aspx

Nilotinib (Tasigna) targeted therapy side effects, how it's given, how it works, precautions and self care tips for treatment of chronic myeloid leukemia.

www.rxlist.com/tasigna-drug.htm

Nilotinib drug substance, a monohydrate monohydrochloride, is a white to slightly yellowish to slightly greenish yellow powder with the anhydrous molecular ...

www.drugs.com/cdi/nilotinib.html

Easy to read patient leaflet for nilotinib. Includes indications, proper use, special instructions, precautions, and possible side effects.

reference.medscape.com/drug/tasigna-nilotinib-342198

Medscape - Chronic myeloid leukemia (CML) dosing for Tasigna (nilotinib), frequency-based adverse effects, comprehensive interactions, contraindications,  ...